IN2014MN01552A - - Google Patents

Info

Publication number
IN2014MN01552A
IN2014MN01552A IN1552MUN2014A IN2014MN01552A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A IN 1552MUN2014 A IN1552MUN2014 A IN 1552MUN2014A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A
Authority
IN
India
Prior art keywords
geranylgeranylacetone
alone
mixture
retinal diseases
retinal
Prior art date
Application number
Other languages
English (en)
Inventor
KUROSETakahiro
MIYANOTakayuki
KATOMariyo
Yoshihiro Takai
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of IN2014MN01552A publication Critical patent/IN2014MN01552A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1552MUN2014 2012-02-27 2013-02-25 IN2014MN01552A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012040803 2012-02-27
PCT/JP2013/054774 WO2013129315A1 (ja) 2012-02-27 2013-02-25 網膜疾患の予防、改善、又は治療剤

Publications (1)

Publication Number Publication Date
IN2014MN01552A true IN2014MN01552A (ja) 2015-05-08

Family

ID=49082513

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1552MUN2014 IN2014MN01552A (ja) 2012-02-27 2013-02-25

Country Status (7)

Country Link
US (2) US20130303625A1 (ja)
JP (2) JP5345744B1 (ja)
CN (1) CN104136015B (ja)
HK (1) HK1200111A1 (ja)
IN (1) IN2014MN01552A (ja)
TW (1) TWI566771B (ja)
WO (1) WO2013129315A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104136015B (zh) * 2012-02-27 2016-11-09 日本乐敦制药株式会社 视网膜疾病的预防、改善或治疗剂
JP5687395B2 (ja) * 2013-02-19 2015-03-18 ロート製薬株式会社 網膜疾患の予防、改善、又は治療用粘膜適用剤
WO2015029925A1 (ja) * 2013-08-26 2015-03-05 ロート製薬株式会社 網膜疾患の予防、改善、又は治療剤
WO2015129809A1 (ja) * 2014-02-28 2015-09-03 国立大学法人京都大学 虚血性眼疾患の処置用の医薬組成物
CN108998006B (zh) * 2018-07-20 2021-06-08 合肥工业大学 一种环境友好的应变响应型荧光超分子材料及其制备方法
JP7430719B2 (ja) * 2018-10-19 2024-02-13 メディシノバ・インコーポレイテッド イブジラストを用いて眼疾患／障害または損傷を治療する方法
CN109470534B (zh) * 2018-11-12 2021-05-25 山东骏腾医疗科技有限公司 一种病理组织透明脱蜡液及其制备方法
CN109675038A (zh) * 2019-02-01 2019-04-26 杭州赫尔斯科技有限公司 增强低浓度阿托品类药物安全性和临床疗效的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192073A (ja) * 1992-12-24 1994-07-12 Eisai Co Ltd 細胞分化誘導剤
JP3560072B2 (ja) 1994-05-20 2004-09-02 エーザイ株式会社 外用基剤
JPH08133967A (ja) * 1994-11-02 1996-05-28 Eisai Co Ltd ドライアイ治療剤
JP2000319170A (ja) 1999-03-05 2000-11-21 Eisai Co Ltd テプレノン含有点眼剤
US20050009772A1 (en) * 2003-05-06 2005-01-13 The Regents Of The University Of California Methods and compositions for the treatment of glaucoma and other retinal diseases
AU2006272586A1 (en) * 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Use of heat shock to treat ocular disease
JP2009502954A (ja) 2005-07-27 2009-01-29 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド タンパク質のミスフォールディングを修正する小分子及びその使用
BR112013003682A2 (pt) 2010-09-01 2016-09-06 Coyote Pharmaceuticals Inc métodos para tratar doenças neurodegenerativas
CN104136015B (zh) 2012-02-27 2016-11-09 日本乐敦制药株式会社 视网膜疾病的预防、改善或治疗剂

Also Published As

Publication number Publication date
TWI566771B (zh) 2017-01-21
US9724312B2 (en) 2017-08-08
US20140128475A1 (en) 2014-05-08
WO2013129315A1 (ja) 2013-09-06
HK1200111A1 (en) 2015-07-31
JP5345744B1 (ja) 2013-11-20
CN104136015B (zh) 2016-11-09
CN104136015A (zh) 2014-11-05
JPWO2013129315A1 (ja) 2015-07-30
US20130303625A1 (en) 2013-11-14
JP2013213049A (ja) 2013-10-17
TW201338771A (zh) 2013-10-01

Similar Documents

Publication Publication Date Title
IN2014MN01552A (ja)
CL2017001195A1 (es) Compuestos de microarn y métodos de modulación de la actividad de mir-21 (divisional de solicitud 2844-2014)
PH12014501718A1 (en) Novel therapeutic agents
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
PH12014501656A1 (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
MY185016A (en) Progenitor cells of mesodermal lineage
MX2013008192A (es) Inhibidores de bace-2 para tratamiento de transtornos metabolicos.
MX2015013275A (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevencion de enfermedades o afecciones asociadas con difucion mitocondrial.
IN2014DN06104A (ja)
BR112014015342A2 (pt) células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano
PH12014502805A1 (en) Novel indanesulfamide derivative
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
MX359002B (es) Metodo y composicion para prevenir la interrupcion y agregacion de celulas madre.
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
IN2014MN01551A (ja)
PH12015501561A1 (en) Method of treatment of diseases
WO2014005153A3 (en) Methods for treating mds1-evi1 mediated cancer
PH12015501109A1 (en) Novel compounds as diacylglycerol acyltransferase inhibitors
NZ612843A (en) Pheromone composition
MX342186B (es) Concentrado alimenticio en forma de gel, y proceso para prepararlo.
MX337593B (es) Gemcabeno y derivados para tratar la pancreatitis.
MX353587B (es) Formulaciones farmacéuticas que contienen ipidacrina y su uso para el tratamiento de trastornos de potencia y trastornos de otras formas de actividad sexual.
UA53379U (ru) Суспензионный крем для лечения воспалительных стоматологических заболеваний
UA59871U (ru) Способ ликвидации последствий фосфорной аварии и нейтрализации желтого фосфора